Each Friday, Oncology Nursing News poses a question on Facebook, Twitter, and Instagram and invites readers to share their thoughts and experiences with each other. Here’s what readers had to say about the thoughtful comments of their patients, and how their job has changed their outlook on life.
Each Friday, Oncology Nursing News poses a question on Facebook, Twitter, and Instagram and invites readers to share their thoughts and experiences with each other.
In recent weeks, when asked about the nicest thing a patient has ever said or done for them, along with how their work has changed their lives, oncology nurses took to the comments section to share their insights. Here’s what some of them had to say:
FDA Approves Encorafenib Plus Cetuximab and Chemo in BRAF V600E-Positive Metastatic CRC
Published: December 20th 2024 | Updated: December 20th 2024The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of metastatic colorectal cancer harboring a BRAF V600E mutation.
FDA Approves Encorafenib Plus Cetuximab and Chemo in BRAF V600E-Positive Metastatic CRC
Published: December 20th 2024 | Updated: December 20th 2024The FDA has granted approval for the use of encorafenib in combination with cetuximab and mFOLFOX6 for the treatment of metastatic colorectal cancer harboring a BRAF V600E mutation.
2 Commerce Drive
Cranbury, NJ 08512